Close Menu

NEW YORK (GenomeWeb) – A team led by researchers at the Spanish National Cancer Research Center and Utrecht University have identified a set of protein kinases that are predictive of treatment outcomes in triple-negative breast cancer.

Published today in Nature Communications, the study used a combination of mass spec-based phosphoproteomics and immunohistochemistry to identify six kinases whose activation levels can help predict the likelihood of relapse and guide therapy in TNBC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.